cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/cc4bdpj
title: CCDC 129167: Experimental Crystal Structure Determination

description: Related Article: S.Malhotra, V.S.Parmar, W.Errington|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1442|doi:10.1107/S0108270197007294
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bdlf
title: CCDC 129164: Experimental Crystal Structure Determination

description: Related Article: A.L.Lane, K.J.Rossiter, C.S.Sell, D.J.Watkin|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1444|doi:10.1107/S0108270197008470
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bg74
title: CCDC 129215: Experimental Crystal Structure Determination

description: Related Article: D.C.Swenson, M.Yamamoto, D.J.Burton|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1445|doi:10.1107/S0108270197003764
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bf3z
title: CCDC 129180: Experimental Crystal Structure Determination

description: Related Article: N.Okabe, C.Inubushi|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1449|doi:10.1107/S0108270197006525
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bg85
title: CCDC 129216: Experimental Crystal Structure Determination

description: Related Article: D.C.Swenson, M.R.TePaske, N.C.Baenziger, J.B.Gloer|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1447|doi:10.1107/S0108270197003776
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bfnj
title: CCDC 129197: Experimental Crystal Structure Determination

description: Related Article: O.bin Shawkataly, K.Ramalingam, S.Selvakumar, Hoong-Kun Fun, A.R.Ibrahim|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1451|doi:10.1107/S0108270197006045
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/cc4bfpk
title: CCDC 129198: Experimental Crystal Structure Determination

description: Related Article: Hoong-Kun Fun, Zhong-Lin Lu, Chun-Ying Duan, Yu-Peng Tian, Xiao-Zeng You, Yu-Mei Guo, Xiao-Yang Gong|1997|Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.|53|1452|doi:10.1107/S0108270197008135
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.3886/e243457
title: COVID-19 Cases Among Healthcare Personnel, by week - ARCHIVED

description: Weekly cases among healthcare personnel, by week

Note: Rows marked by "missing date fields" represent healthcare worker cases that were not associated with a date.
description: (Downloaded 1/10/2026)
DOI: 10.3886/e243457v1
title: COVID-19 Cases Among Healthcare Personnel, by week - ARCHIVED

description: Weekly cases among healthcare personnel, by week

Note: Rows marked by "missing date fields" represent healthcare worker cases that were not associated with a date.
description: (Downloaded 1/10/2026)
DOI: 10.3886/e243458
title: COVID-19 Weekly Cases and Deaths by Age, Race/Ethnicity, and Sex - ARCHIVED

description: Note:
Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.


This table summarizes COVID-19 case and death data submitted to CDC as case reports for the line-level dataset. Case and death counts are stratified according to sex, age, and race and ethnicity at regional and national levels. Data for US territories are included in case and death counts, but not population counts. Weekly cumulative counts with five or fewer cases or deaths are not reported to protect confidentiality of patients. Records with unknown or missing sex, age, or race and ethnicity and of multiple, non-Hispanic race and ethnicity are included in case and death totals. COVID-19 case and death data are provisional and are subject to change. Visualization of COVID-19 case and death rate trends by demographic variables may be viewed on COVID Data Tracker (https://covid.cdc.gov/covid-data-tracker/#demographicsovertime).
Read less
description: (Downloaded 1/10/2026)
DOI: 10.3886/e243458v1
title: COVID-19 Weekly Cases and Deaths by Age, Race/Ethnicity, and Sex - ARCHIVED

description: Note:
Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.


This table summarizes COVID-19 case and death data submitted to CDC as case reports for the line-level dataset. Case and death counts are stratified according to sex, age, and race and ethnicity at regional and national levels. Data for US territories are included in case and death counts, but not population counts. Weekly cumulative counts with five or fewer cases or deaths are not reported to protect confidentiality of patients. Records with unknown or missing sex, age, or race and ethnicity and of multiple, non-Hispanic race and ethnicity are included in case and death totals. COVID-19 case and death data are provisional and are subject to change. Visualization of COVID-19 case and death rate trends by demographic variables may be viewed on COVID Data Tracker (https://covid.cdc.gov/covid-data-tracker/#demographicsovertime).
Read less
description: (Downloaded 1/10/2026)
DOI: 10.6084/m9.figshare.30795251
title: Dataset: Use of leg-mounted monitors to assess the effects of treponeme-associated hoof disease on elk (Cervus canadensis) activity

description: Attached is the dataset to accompany the manuscript entitled: "Use of leg-mounted monitors to assess the effects of treponeme-associated hoof disease on elk (Cervus canadensis) activity" submitted by Hill et al. to <i>Animals.</i>
DOI: 10.6084/m9.figshare.30795251.v1
title: Dataset: Use of leg-mounted monitors to assess the effects of treponeme-associated hoof disease on elk (Cervus canadensis) activity

description: Attached is the dataset to accompany the manuscript entitled: "Use of leg-mounted monitors to assess the effects of treponeme-associated hoof disease on elk (Cervus canadensis) activity" submitted by Hill et al. to <i>Animals.</i>
DOI: 10.15468/dl.vk8rn5
title: Occurrence Download

description: A dataset containing 138146137 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is iNaturalist Research-grade Observations"
 ]
}

 The dataset includes 138146137 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0003211-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3886/e243459
title: 2022–2023 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates

description: CDC is collaborating with Vitalant Research Institute, American Red Cross, and Westat Inc. to conduct a nationwide COVID-19 seroprevalence survey of blood donors. De-identified blood samples are tested for antibodies to SARS-CoV-2 to better understand the percentage of people in the United States who have antibodies against SARS-CoV-2 (the virus that causes COVID-19) and to track how this percentage changes over time. Both SARS-CoV-2 infection and COVID-19 vaccines currently used in the United States result in production of anti-spike (anti-S) antibodies but only infection results in production of anti-nucleocapsid (anti-N) antibodies.
Infection-induced seroprevalence estimates the proportion of the population with antibody evidence of previous SARS-CoV-2 infection and refers to the percent of the population with anti-nucleocapsid antibodies.
Combined infection-Induced and Vaccination-Induced seroprevalence estimates the proportion of the population with antibody evidence of previous SARS-CoV-2 infection, COVID-19 vaccination, or both, and refers to the percent of the population that has anti-spike antibodies, anti-nucleocapsid antibodies, or both.

This link connects to a webpage that displays the data from the Nationwide Blood Donor Seroprevalence Survey. It offers an interactive visualization available at https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022
Read less
description: (Downloaded 1/10/2026)
DOI: 10.3886/e243459v1
title: 2022–2023 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates

description: CDC is collaborating with Vitalant Research Institute, American Red Cross, and Westat Inc. to conduct a nationwide COVID-19 seroprevalence survey of blood donors. De-identified blood samples are tested for antibodies to SARS-CoV-2 to better understand the percentage of people in the United States who have antibodies against SARS-CoV-2 (the virus that causes COVID-19) and to track how this percentage changes over time. Both SARS-CoV-2 infection and COVID-19 vaccines currently used in the United States result in production of anti-spike (anti-S) antibodies but only infection results in production of anti-nucleocapsid (anti-N) antibodies.
Infection-induced seroprevalence estimates the proportion of the population with antibody evidence of previous SARS-CoV-2 infection and refers to the percent of the population with anti-nucleocapsid antibodies.
Combined infection-Induced and Vaccination-Induced seroprevalence estimates the proportion of the population with antibody evidence of previous SARS-CoV-2 infection, COVID-19 vaccination, or both, and refers to the percent of the population that has anti-spike antibodies, anti-nucleocapsid antibodies, or both.

This link connects to a webpage that displays the data from the Nationwide Blood Donor Seroprevalence Survey. It offers an interactive visualization available at https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022
Read less
description: (Downloaded 1/10/2026)
DOI: 10.34740/kaggle/dsv/14467869
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.3886/e242827
title: Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024-25 and 2023-24 Seasons, by Age Group and Jurisdiction, United States

description: Monthly Cumulative Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 202425 and 202324 Seasons, by Age Group and Jurisdiction, by Age Group and Jurisdiction

 COVID-19 vaccination coverage for children and adults is assessed through U.S. jurisdictions Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/)
Read less
description: (Downloaded 1/8/2026)
DOI: 10.3886/e242827v1
title: Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024-25 and 2023-24 Seasons, by Age Group and Jurisdiction, United States

description: Monthly Cumulative Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 202425 and 202324 Seasons, by Age Group and Jurisdiction, by Age Group and Jurisdiction

 COVID-19 vaccination coverage for children and adults is assessed through U.S. jurisdictions Immunization Information Systems Resources (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group (https://www.cdc.gov/iis/about/)
Read less
description: (Downloaded 1/8/2026)
DOI: 10.5281/zenodo.18140555
title: Heterogeneity of Cardiac regression

description: MergedExpression includes Fastong-,Debanding-,  and Activin- induced regression
DOI: 10.5281/zenodo.18216193
title: Lumbriculus database for the publication: Reflecting on 20 Years of OECD 225: Advancing standardised ecotoxicological testing with Lumbriculus variegatus.

description: The Lumbriculus database contains all reviewed records of a systematic literature search of the ecotoxicological studies using Lumbriculus variegatus published since the development of OECD 225 in 2007. A first literature search was performed with PubMed (last search: 18/08/2025), using the search string: (toxi* OR hazard* OR risk* OR chemic*) AND (Lumbriculus variegatus). The search returned 237 studies (Figure 1). Another search was performed with Web of Science (last search: 23/12/2025): TS=((toxic* OR hazard* OR "risk assessment") AND (Lumbriculus variegatus) AND (ecotoxic* OR aquatic OR freshwater OR invertebrate* OR "environmental exposure" OR "environmental pollut*")) AND PY=(2007-2025). The search returned 216 studies. In addition to the database searches, we identified two relevant studies through alternative routes (e.g., expert knowledge). These studies did not appear in our initial Web of Science or PubMed searches, but they were included because they met all predefined eligibility criteria (see Section 2.2). After removal of duplicates (n = 152), 303 papers using L. variegatus in ecotoxicological studies from 2007 to 2025 were identified. In total, 91 out of the 303 studies met the inclusion criteria described in the paper for a more detailed analysis.
DOI: 10.5281/zenodo.18216192
title: Lumbriculus database for the publication: Reflecting on 20 Years of OECD 225: Advancing standardised ecotoxicological testing with Lumbriculus variegatus.

description: The Lumbriculus database contains all reviewed records of a systematic literature search of the ecotoxicological studies using Lumbriculus variegatus published since the development of OECD 225 in 2007. A first literature search was performed with PubMed (last search: 18/08/2025), using the search string: (toxi* OR hazard* OR risk* OR chemic*) AND (Lumbriculus variegatus). The search returned 237 studies (Figure 1). Another search was performed with Web of Science (last search: 23/12/2025): TS=((toxic* OR hazard* OR "risk assessment") AND (Lumbriculus variegatus) AND (ecotoxic* OR aquatic OR freshwater OR invertebrate* OR "environmental exposure" OR "environmental pollut*")) AND PY=(2007-2025). The search returned 216 studies. In addition to the database searches, we identified two relevant studies through alternative routes (e.g., expert knowledge). These studies did not appear in our initial Web of Science or PubMed searches, but they were included because they met all predefined eligibility criteria (see Section 2.2). After removal of duplicates (n = 152), 303 papers using L. variegatus in ecotoxicological studies from 2007 to 2025 were identified. In total, 91 out of the 303 studies met the inclusion criteria described in the paper for a more detailed analysis.
DOI: 10.3886/e243463
title: United States COVID-19 County Level Data Sources - ARCHIVED

description: The Public Health Emergency (PHE) declaration for COVID-19 expired on May 11, 2023. As a result, the Aggregate Case and Death Surveillance System will be discontinued. Although these data will continue to be publicly available, this dataset will no longer be updated.

On October 20, 2022, CDC began retrieving aggregate case and death data from jurisdictional and state partners weekly instead of daily.

This dataset includes the URLs that were used by the aggregate county data collection process that compiled aggregate case and death counts by county. Within this file, each of the states (plus select jurisdictions and territories) are listed along with the county web sources which were used for pulling these numbers. Some states had a single statewide source for collecting the county data, while other states and local health jurisdictions may have had standalone sources for individual counties. In the cases where both local and state web sources were listed, a composite approach was taken so that the maximum value reported for a location from either source was used. The initial raw data were sourced from these links and ingested into the CDC aggregate county dataset before being published on the COVID Data Tracker.
Read less
description: (Downloaded 1/10/2026)
DOI: 10.3886/e243463v1
title: United States COVID-19 County Level Data Sources - ARCHIVED

description: The Public Health Emergency (PHE) declaration for COVID-19 expired on May 11, 2023. As a result, the Aggregate Case and Death Surveillance System will be discontinued. Although these data will continue to be publicly available, this dataset will no longer be updated.

On October 20, 2022, CDC began retrieving aggregate case and death data from jurisdictional and state partners weekly instead of daily.

This dataset includes the URLs that were used by the aggregate county data collection process that compiled aggregate case and death counts by county. Within this file, each of the states (plus select jurisdictions and territories) are listed along with the county web sources which were used for pulling these numbers. Some states had a single statewide source for collecting the county data, while other states and local health jurisdictions may have had standalone sources for individual counties. In the cases where both local and state web sources were listed, a composite approach was taken so that the maximum value reported for a location from either source was used. The initial raw data were sourced from these links and ingested into the CDC aggregate county dataset before being published on the COVID Data Tracker.
Read less
description: (Downloaded 1/10/2026)
DOI: 10.5281/zenodo.18062513
title: Lumbriculus database for the publication: Reflecting on 20 Years of OECD 225: Advancing standardised ecotoxicological testing with Lumbriculus variegatus.

description: The Lumbriculus database contains all reviewed records of a systematic literature search of the ecotoxicological studies using Lumbriculus variegatus published since the development of OECD 225 in 2007. A first literature search was performed with PubMed (last search: 18/08/2025), using the search string: (toxi* OR hazard* OR risk* OR chemic*) AND (Lumbriculus variegatus). The search returned 237 studies (Figure 1). Another search was performed with Web of Science (last search: 23/12/2025): TS=((toxic* OR hazard* OR "risk assessment") AND (Lumbriculus variegatus) AND (ecotoxic* OR aquatic OR freshwater OR invertebrate* OR "environmental exposure" OR "environmental pollut*")) AND PY=(2007-2025). The search returned 216 studies. In addition to the database searches, we identified two relevant studies through alternative routes (e.g., expert knowledge). These studies did not appear in our initial Web of Science or PubMed searches, but they were included because they met all predefined eligibility criteria (see Section 2.2). After removal of duplicates (n = 152), 303 papers using L. variegatus in ecotoxicological studies from 2007 to 2025 were identified. In total, 91 out of the 303 studies met the inclusion criteria described in the paper for a more detailed analysis.
DOI: 10.34740/kaggle/dsv/14467893
title: Dataset jadwal event lariku.info
DOI: 10.6084/m9.figshare.31045441
title: Research Data

description: Research Data:Questionnaire DataResearch QuestionnaireDescriptive Analysis Results
DOI: 10.6084/m9.figshare.31045441.v1
title: Research Data

description: Research Data:Questionnaire DataResearch QuestionnaireDescriptive Analysis Results
DOI: 10.3886/e243464
title: 2020-2021 Nationwide Blood Donor Seroprevalence Survey Infection-Induced Seroprevalence Estimates

description: CDC is collaborating with the National Institutes of Health (NIH), the Food and Drug Administration (FDA), Vitalant Research Institute (VRI), Westat Inc., and numerous blood collection organizations across the United States to conduct a nationwide COVID-19 seroprevalence survey of blood donors. This is the largest nationwide COVID-19 seroprevalence survey to date. De-identified blood samples are tested for antibodies to SARS-CoV-2 to better understand the percentage of people in the United States who have antibodies against SARS-CoV-2 (the virus that causes COVID-19) and to track how this percentage changes over time. Both SARS-CoV-2 infection and COVID-19 vaccines currently used in the United States result in production of anti-spike (anti-S) antibodies but only infection results in production of anti-nucleocapsid (anti-N) antibodies. Infection-induced seroprevalence estimates the proportion of the population with evidence of previous SARS-CoV-2 infection and refers to the prevalence of the population with both anti-S and anti-N antibodies.

This link connects to a webpage that displays the data from the Nationwide Blood Donor Seroprevalence Survey. It offers an interactive visualization available at https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence

Additional information is available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/blood-bank-serosurvey.html
Read less
description: (Downloaded 1/10/2026)